| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GYRE THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 250K | Aug 5, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | Aug 5, 2025 | 1 | $0 | 4 | Aug 7, 2025 | Director |
| GYRE | GYRE THERAPEUTICS, INC. | May 27, 2025 | 1 | $0 | 4 | May 28, 2025 | Director |
| GYRE | GYRE THERAPEUTICS, INC. | Jan 5, 2025 | 1 | $0 | 4 | Jan 7, 2025 | Director |
| GYRE | GYRE THERAPEUTICS, INC. | Jan 5, 2025 | 0 | $0 | 3 | Jan 7, 2025 | Director |